Cadrenal Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-157/15/26 | New | $8,843,849 | $8,843,849 | Other | 06b | SEC linkSEC |
| 2026-04-064/6/26 | New | $7,923,235 | $7,923,235 | Other | 06b | SEC linkSEC |
| 2025-12-3112/31/25 | New | $4,396,329 | $4,396,329 | Other | 06b | SEC linkSEC |
| 2024-11-1411/14/24 | New | $9,428,594 | $9,428,594 | Other | 06b | SEC linkSEC |
| 2023-07-187/18/23 | New | $7,500,001 | $7,500,001 | Other | 06b | SEC linkSEC |
| 2022-12-0812/8/22 | New | $250,000 | $250,000 | Debt Only | 06b | SEC linkSEC |
| 2022-07-257/25/22 | New | $150,000 | $150,000 | Debt Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Jeffrey S. Cole | Executive |
| Jeff Cole | Executive |
| James J. Ferguson | Executive |
| Lee Golden | Director |
| Robert Lisicki | Director |
| Douglas W. Losordo | Executive |
| John R. Murphy | Director |
| Quang X. Pham | Director, Executive |
| John P. Sharp | Executive |
| Matthew Szot | Executive |
| Glynn Wilson | Director |
| Steven Zelenkofske | Director |
Industry: Biotechnology (See others in industry)
Address:
822 A1 A North, Suite 306
Ponte Vedra, FL, 32082
Phone: (904) 300-0701
Ponte Vedra, FL, 32082
Phone: (904) 300-0701